14th regional workshop via webinar on "Pharmacovigilance and Establishment of Pharmacovigilance System in Pharmaceutical Industries- A Way Forward" on 9th October 2020
  Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection (in supersession of previous advisory dated 23rd March, 2020) 
  Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products
  List of ADR Monitoring Centres under Pharmacovigilance Programme of India 
  Orders & Circulars 
  PvPI Performance Report  
  MoU between IPC,NCC-PvPI and NABH
  WHO Appreciation Letter to MoHFW for successful National Regulatory Authority(NRA) Assessment
  Office order for submission of Source Documents 
  Minutes of Meeting on "4th Interactive Session on Participation of marketing Authorization Holders(MAHs) in PvPI" 
  ADRs Reporting Status of AMCs
  Stakeholder Feedback form 
  PvPI Newsletters 
  Monthly Progress Report (PvPI)
  Letter of Intent 
  Adverse Drug Reaction Reporting Form for Healthcare Professionals Version-1.3 
  PvPI-Frequently asked questions
  Union Health Minister inaugurated the 38th Annual Meeting of Representatives of National                         
    Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring
  PvPI-Frequently asked questions
 Guidance Document for spontaneous Adverse Drug Reaction Reporting 
  Partners Roles and Responsibilities in Ensuring Vaccines Safety
  Serious AEFI Case notification form